Related references
Note: Only part of the references are listed.Cost-of-illness studies in heart failure: a systematic review 2004-2016
Wladimir Lesyuk et al.
BMC CARDIOVASCULAR DISORDERS (2018)
Conflicting vascular and metabolic impact of the IL-33/sST2 axis
Raffaele Altara et al.
CARDIOVASCULAR RESEARCH (2018)
Translational Challenges in Atrial Fibrillation
Jordi Heijman et al.
CIRCULATION RESEARCH (2018)
Soluble ST2 in Patients with Nonvalvular Atrial Fibrillation and Prediction of Heart Failure
Changxi Chen et al.
INTERNATIONAL HEART JOURNAL (2018)
Fibrosis Marker Soluble ST2 Predicts Atrial Fibrillation Recurrence after Cryoballoon Catheter Ablation of Nonvalvular Paroxysmal Atria Fibrillation
Sefa Okar et al.
KOREAN CIRCULATION JOURNAL (2018)
Long-Term Outcomes in Patients With Type 2 Myocardial Infarction and Myocardial Injury
Andrew R. Chapman et al.
CIRCULATION (2018)
Fourth Universal Definition of Myocardial Infarction (2018)
Kristian Thygesen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
sST2 Predicts Outcome in Chronic Heart Failure Beyond N-proBNP and High-Sensitivity Troponin T
Michele Emdin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
ST2: Current status
Aditi Dattagupta et al.
INDIAN HEART JOURNAL (2018)
Characteristics and occurrence of type 2 myocardial infarction in emergency department patients: a prospective study
Jaimi H. Greenslade et al.
EMERGENCY MEDICINE JOURNAL (2018)
Rationale and design of TRANSITION: a randomized trial of pre-discharge vs. post-discharge initiation of sacubitril/valsartan
Domingo Pascual-Figal et al.
ESC HEART FAILURE (2018)
Dowe need another heart failure biomarker: focus on soluble suppression of tumorigenicity 2 (sST2)
Alan S. Maisel et al.
EUROPEAN HEART JOURNAL (2017)
Association of sST2 and hs-CRP levels with new-onset atrial fibrillation in coronary artery disease
Santeri Nortamo et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Type 2 myocardial infarction: incidence, presentation, treatment and outcome in routine clinical practice
Dragana Radovanovic et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2017)
Prognostic Value of Serial ST2 Measurements in Patients With Acute Heart Failure
Laura C. van Vark et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure
Alberto Aimo et al.
JACC-HEART FAILURE (2017)
Prognostic Value of Soluble ST2 After Myocardial Infarction: A Community Perspective
William S. Jenkins et al.
AMERICAN JOURNAL OF MEDICINE (2017)
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
Clyde W. Yancy et al.
CIRCULATION (2017)
Ablation of IL-33 gene exacerbate myocardial remodeling in mice with heart failure induced by mechanical stress
Punniyakoti T. Veeraveedu et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Soluble ST2 Testing: A Promising Biomarker in the Management of Heart Failure
Humberto Villacorta et al.
ARQUIVOS BRASILEIROS DE CARDIOLOGIA (2016)
ST2 receptor invalidation maintains wound inflammation, delays healing and increases fibrosis
James S. Lee et al.
EXPERIMENTAL DERMATOLOGY (2016)
Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration
Virpi Talman et al.
CELL AND TISSUE RESEARCH (2016)
Interleukin 33 is a guardian of barriers and a local alarmin
Nikolas T. Martin et al.
NATURE IMMUNOLOGY (2016)
Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure
W. H. Wilson Tang et al.
JACC-HEART FAILURE (2016)
Serial ST2 Testing in Hospitalized Patients With Acute Heart Failure
Alan S. Maisel et al.
AMERICAN JOURNAL OF CARDIOLOGY (2015)
ST2 and Prognosis in Acutely Decompensated Heart Failure: The International ST2 Consensus Panel
James L. Januzzi et al.
AMERICAN JOURNAL OF CARDIOLOGY (2015)
High-Sensitivity Cardiac Troponin I and B-Type Natriuretic Peptide as Predictors of Vascular Events in Primary Prevention Impact of Statin Therapy
Brendan M. Everett et al.
CIRCULATION (2015)
Serial soluble ST2 for the monitoring of pharmacologically optimised chronic stable heart failure
Susan E. Piper et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Avoiding the Imminent Plague of Troponinitis The Need for Reference Limits for High-Sensitivity Cardiac Troponin T
Christopher M. Kramer
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Biological variation of galectin-3 and soluble ST2 for chronic heart failure: Implication on interpretation of test results
Alan H. B. Wu et al.
AMERICAN HEART JOURNAL (2013)
Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: The Multinational Observational Cohort on Acute Heart Failure (MOCA) study
Johan Lassus et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Soluble ST2 Serum Concentration and Renal Function in Heart Failure
Antoni Bayes-Genis et al.
JOURNAL OF CARDIAC FAILURE (2013)
Heart Failure Therapy-Induced Early ST2 Changes May Offer Long-Term Therapy Guidance
Tobias Breidthardt et al.
JOURNAL OF CARDIAC FAILURE (2013)
A Novel Cardiac Bio-Marker: ST2: A Review
Marco Matteo Ciccone et al.
MOLECULES (2013)
Serial Monitoring of Soluble Interleukin Family Member ST2 in Patients with Acutely Decompensated Heart Failure
S. Manzano-Fernandez et al.
CARDIOLOGY (2012)
Role of ST2 in Non-ST-Elevation Acute Coronary Syndrome in the MERLIN-TIMI 36 Trial
Payal Kohli et al.
CLINICAL CHEMISTRY (2012)
Distribution and Clinical Correlates of the Interleukin Receptor Family Member Soluble ST2 in the Framingham Heart Study
Erin E. Coglianese et al.
CLINICAL CHEMISTRY (2012)
Usefulness of Soluble Concentrations of Interleukin Family Member ST2 as Predictor of Mortality in Patients With Acutely Decompensated Heart Failure Relative to Left Ventricular Ejection Fraction
Sergio Manzano-Fernandez et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure
Domingo A. Pascual-Figal et al.
EUROPEAN JOURNAL OF HEART FAILURE (2011)
The IL-33/ST2 pathway - A new therapeutic target in cardiovascular disease
Ashley M. Miller et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Interleukin-33 Induces Protective Effects in Adipose Tissue Inflammation During Obesity in Mice
Ashley M. Miller et al.
CIRCULATION RESEARCH (2010)
Interleukin family member ST2 and mortality in acute dyspnoea
T. Socrates et al.
JOURNAL OF INTERNAL MEDICINE (2010)
Serum Soluble ST2 A Potential Novel Mediator in Left Ventricular and Infarct Remodeling After Acute Myocardial Infarction
Robin A. P. Weir et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction
Marc S. Sabatine et al.
CIRCULATION (2008)
Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure
Thomas Mueller et al.
CLINICAL CHEMISTRY (2008)
Serial Sampling of ST2 Predicts 90-Day Mortality Following Destabilized Heart Failure
Saskia Boisot et al.
JOURNAL OF CARDIAC FAILURE (2008)
IL-33 reduces the development of atherosclerosis
Ashley M. Miller et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Nonmyocardial Production of ST2 Protein in Human Hypertrophy and Failure Is Related to Diastolic Load
Jozef Bartunek et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Economic burden of heart failure in the elderly
Lawrence Liao et al.
PHARMACOECONOMICS (2008)
Measurement of the interleukin family member ST2 in patients with acute dyspnea
James L. Januzzi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Regulation of cardiac hypertrophy by intracellular signalling pathways
Joerg Heineke et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
J Schmitz et al.
IMMUNITY (2005)
The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study
JL Januzzi et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction
M Shimpo et al.
CIRCULATION (2004)
Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction
EO Weinberg et al.
CIRCULATION (2002)
Share Paper
